Table 2.
Projected Impact of HIVDR on AIDS Deaths, New Infections, and ART Costs in Sub–Saharan Africa 2016–2030.a
AIDS Deaths | New Infections | ART Costs | |
With HIVDR (Fast-track projections) |
5.6 million | 5.1 million | $ 83 billion |
Current level of PDR <10% | |||
Percentage attributable to HIVDR | 13% | 7% | 6% |
Amount attributable to HIVDR | 710,000 | 380 000 | $5.0 billion |
Current level of PDR ≥10% | |||
Percentage attributable to HIVDR | 16% | 9% | 8% |
Amount attributable to HIVDR | 890 000 | 450 000 | $6.5 billion |
Abbreviations: HIV, human immunodeficiency virus; HIVDR, HIV drug resistance; PDR, pretreatment HIV drug resistance.
aUsing the Spectrum Goals Model estimates [6] by applying the impact of drug resistance as estimated using the HIV Synthesis Model.